The present disclosure provides, inter alia, multi-drug Antibody Drug Conjugates (MD- ADCs) and Linking Assembly (LA) Units that are constructed in a site-specific matter via 'orthogonal' deprotection and drug loading. Also provided are, Protected Linking Assembly Units, which allow for 'orthogonal' deprotection and construction of MD- ADCs and LA Units of the present disclosure.